🇺🇸 Placebo zonisamide in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 1
Most-reported reactions
- Toxic Skin Eruption — 1 report (100%)
Other Neurology approved in United States
Frequently asked questions
Is Placebo zonisamide approved in United States?
Placebo zonisamide does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Placebo zonisamide in United States?
Rose Research Center, LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.